ROCHESTER, N.Y., Oct. 25, 2018 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce that seeCOLe (see Clinical data On Lens), a health app for the Vuzix Blade® that enables clinicians to navigate and document into their patient electronic health records by hands-free by voice command, was awarded first place at the Cerner Corporation Code App Challenge during the 2018 Cerner Health Conference held in Kansas City, MO on October 9-11.
Cerner Corporation's health technologies connect people and information systems at more than 27,500 contracted provider facilities worldwide and are dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. Cerner brings together thousands of medical professionals each year at their annual Cerner Health Conference and at this year's conference they hosted the code App Challenge, which gives third-party developers and Cerner health systems the opportunity to create, develop, and pitch innovative solutions to improve health outcomes.
seeCOLe, which stands for "see Clinical data On Lens", is an augmented reality health app that uses SMART on FHIR (Fast Healthcare Interoperability Resource), which enables clinicians to navigate and document information into their organizations' electronic health record system using smart glasses. While using seeCOLe, the clinician's verbal commands can interact with the electronic health record, which populates data from the patient's chart, and display it on the Vuzix Blade Smart Glasses. Once the patient data is accessed, the seeCOLe application can be coached via voice or touch features to navigate through patient records. seeCOLe coupled with the Vuzix Blade provides hands-free documentation of patient data at the bedside, during a consultation, in isolation areas and in the operating room all without losing sight of the patient. The augmented reality solution also provides patient data within the clinician's point of view wirelessly, which enables the clinician to interact freely and increase the clinician-to-patient interaction.
"The overall form factor, wearability and performance of the Vuzix Blade Smart Glasses has drawn rave reviews from B2C customers, who see a tremendous opportunity to disrupt the existing market and build hands-free solutions around the Vuzix Blade platform," said Paul Travers, Vuzix President and Chief Executive Officer. "Innovative health applications like seeCOLe, delivered through a see-through display on the Vuzix Blade Smart Glasses, can not only help clinicians provide improved care, but also increase their interaction with patients."
About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 62 patents and 71 additional patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2018 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, Barcelona, Spain and Tokyo, Japan.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to seeCOLe, the Blade Smart Glasses and the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Media and Investor Relations Contact:
Matt Margolis, Director of Corporate Communications and Investor Relations, Vuzix Corporation [email protected] Tel: (585) 359-5952
Ed McGregor, Director of Institutional Investor Relations, Vuzix Corporation [email protected] Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – [email protected] www.vuzix.com
SOURCE Vuzix Corporation
Share this article